SARS-CoV-2 3CLpro-IN-6

Biorbyt

SARS-CoV-2 3CLpro-IN-6

10

Research Use Only

98.00%

C22H15NO7

405.36

SARS-CoV-2 3CLpro-IN-6 is a reversible covalent inhibitor of the SARS-CoV-2 3CL protease, showing potent inhibitory activity with an IC50 of 4.9 microM, and is used in the research of coronavirus disease 2019 (COVID-19).

N(=O)(=O)C1=C(C=CC=C1)C=2OC(C=C(C(=O)C3=CC=CC=C3)C(C(OC)=O)=O)=CC2

-20°C

12352200